Mezzion Pharmaceuticals, Inc., a late-stage rare disease biopharmaceutical company focused on therapies for patients with single ventricle congenital heart disease and Fontan circulation, today ...
Sometimes a baby is born with certain types of congenital heart problems. In these cases, a type of open heart surgery called the Fontan procedure is done as the final part of a series of surgeries ...
Institutional financing supports continued execution of late-stage program evaluating JURVIGO® (udenafil) in patients living with Fontan circulation FORT LEE, N.J.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results